'First, do no harm': Factors that influence pharmacists making decisions about over-the-counter medication: A qualitative study in Northern Ireland

Drug Safety

Volumn 33, Issue 3, 2010, Pages 245-255

  Hanna, Lezley Anne ^a   Hughes, Carmel M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

ARTICLE; DRUG SAFETY; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; NORMAL HUMAN; PHARMACIST; PHARMACIST ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW;

ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; DECISION MAKING; DECISION MAKING, ORGANIZATIONAL; EVIDENCE-BASED MEDICINE; HUMANS; NONPRESCRIPTION DRUGS; NORTHERN IRELAND; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PROFESSIONAL-PATIENT RELATIONS; SAFETY; SELF MEDICATION;

EID: 76949104824     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11319050-000000000-00000     Document Type: Article

References (51)

1. Blenkinsopp A, Bond C. Over-the-counter medication. London: British Medical Association, 2005
2. The Association of the British Pharmaceutical Industry. Understanding the pharmaceutical price regulation scheme. London: The Association of the British Pharmaceutical Industry, 2005
3. The Medicines and Healthcare products Regulatory Agency (MHRA). Flomax relief MR (PL 00015/0280) UKPAR [online]. Available from URL: http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con068200.pdf [Accessed 2010 Feb 3]
4. The Medicines and Healthcare products Regulatory Agency (MHRA). Recent reclassifications [online]. Available from URL: www.mhra.gov.uk/Howweregulate/ Medicines/Licensingofmedicines/Legalstatusandreclassification/ Recentreclassifications/index.htm [Accessed 2009 Sep 28]
5. The Royal Pharmaceutical Society of Great Britain (RPSGB). Potential candidates for reclassification from POM to P [online]. Available from URL: http://www.rpsgb.org.uk/pdfs/pomtopreclasslist.pdf [Accessed 2009 Mar 27]
6. Department of Health. Promoting clinical effectiveness: a framework for action in and through the NHS. London: Department of Health, 1996
7. Sackett DL, Rosenberg WMC, Gray JM, et al. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-72
8. Royal Pharmaceutical Society of Great Britain. Medicines, ethics and practice: a guide for pharmacists and pharmacy technicians. Issue 33. London: Pharmaceutical Press, 2009 Jul
9. Wazaify M, Hughes CM, McElnay JC. The implementation of a harm minimization model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Educ Couns 2006; 64: 136-141
10. Smith MB, Feldman W. Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1992. JAMA 1993; 269: 2258-2263
11. Smith SM, Schroeder K, Fahey T. Over-the-counter medica-tions for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2008; (1): CD001831
12. Pray WS. Ethical, scientific, and educational concerns with unproven medications. Am J Pharm Edu 2006; 70 (6): 141
13. Colquhoun D. Science degrees without the science. Nature 2007; 446: 373-374
14. Naidu S, Wilkinson JM, Simpson MD. Attitudes of Australian pharmacists toward complementary and alternative medicines. Ann Pharmacother 2005; 39: 1456-1461
15. Ernst E. How much of CAM is based on research evi-dence? Evid Based Complement Alternat Med. Epub 2009 May 21
16. Ernst E. Should we use "powerful placebos"? Pharm J 2004; 273: 795
17. Miller F, Rosenstein D. The nature and power of the pla-cebo effect. J Clin Epi 2006; 59: 331-335
18. Rutter P. Community pharmacy: symptoms, diagnosis and treatment. 2nd ed. Edinburgh: Churchill Livingstone Elsevier, 2009
19. Blenkinsopp A, Paxton P, Blenkinsopp J. Symptoms in the pharmacy: a guide to the management of common illness. 6th ed. Chichester: Wiley-Blackwell, 2009
20. Edwards C, Stillman P. Minor illness or major disease? The clinical pharmacist in the community. 4th ed. London: Pharmaceutical Press, 2006
21. Nathan A. Non-prescription medicines. 3rd ed. London: Pharmaceutical Press, 2006
22. Britten N. Qualitative research: qualitative interviews in medical research. BMJ 1995; 311: 251-253
23. Mays N, Pope C. Qualitative research: rigour and qualita-tive research. BMJ 1995; 311: 109-112
24. Marshall MN. Sampling for qualitative research. Fam Pract 1996; 13: 522-525
25. Sandelowski M. Focus on research methods combining qualitative and quantitative sampling, data collection, and analysis techniques in mixed-method studies. Res Nurs Health 2000; 23: 246-255
26. Tracy CS, Dantas GC, Upshur REG. Evidence-based med-icine in primary care: qualitative study of family physicians. BMC Fam Pract 2003; 4: 6-14
27. Donovan J, Mills N, Smith M, et al. Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (Prostate Testing for Cancer and Treatment) study. BMJ 2002; 325: 766-770
28. Spencer L, Ritchie J, O'Connor W. Analysis: practices, principles and processes. In: Ritchie J, Lewis J, editors. Qualitative research practice. London: Sage Publications, 2004: 199-218
29. Mays N, Pope C. Qualitative research in health care: asses-sing quality in qualitative research. BMJ 2000; 320: 114-116
30. Watson MC, Bond CM. The evidence-based supply of non-prescription medicines: barriers and beliefs. Int J Pharm Pract 2004; 12: 65-72
31. Department of Health. Building on the best: choice, respon-siveness and equity in the NHS. London: Department of Health, 2003 Dec
32. Parliamentary Office of Science and Technology. Changing role of pharmacies. Postnote 2005 Jul, No.246 [online]. Available from URL: http://www.parliament.uk/docu ments/upload/postpn246.pdf [Accessed 2010 Jan 29]
33. Department of Health. The NHS plan: a plan for invest-ment, a plan for reform. Presented to Parliament by the Secretary of State for Health by Command of Her Majesty, 2000 Jul [online]. Available from URL: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyandGuidance/DH-4002960 [Accessed 2009 Dec 29]
34. Shang A, Huwiler-Muntener K, Nartey L, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366: 726-732
35. Stevenson FA, Greenfield SM, Jones M, et al. GPs' per-ceptions of patient influence on prescribing. Fam Pract 1999; 16: 255-261
36. Bradley CP. Uncomfortable prescribing decisions: a critical incident study. BMJ 1992; 304: 294-296
37. Ferner RE, Beard K. Over the counter medicines: proceed with caution. BMJ 2008; 336: 694-696
38. Tracy CS, Dantas GC, Moineddin R, et al. The nexus of evidence, context and patient preferences in primary care: postal survey of Canadian family physicians. BMC Fam Pract 2003; 4: 13-20
39. Marinker M, editor. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain and Merck Sharp & Dohme, 1997
40. Britten N, Weiss M. What is concordance? In: Bond CM, editor. Concordance. London: The Pharmaceutical Press, 2004: 9-28
41. Ring A, Dowrick C, Humphris G, et al. Do patients with unexplained physical symptoms pressurize general practitioners for somatic treatment? A qualitative study. BMJ 2004; 328: 1057-1060
42. Emmerton L, Shaw J. The influence of pharmacy staffing in non-prescription medicine sales. Int J Pharm Pract 2002; 10: 101-106
43. Watson MC, Bond CM, Grimshaw JM, et al. Factors pre-dicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting. Qual Saf Health Care 2006; 15: 53-57
44. Seston E, Nicolson M, Hassell K, et al. 'Not just someone stood behind the counter'. The views and experiences of medicines counter assistants. J Soc Admin Pharm 2001; 18: 122-128
45. Bissell P, Ward P, Noyce P. Appropriateness measurement: application to advice-giving in community pharmacies. Soc Sci Med 2000; 51: 343-359 (Pubitemid 30236195)
46. Ernst E. Is it ethical for pharmacists to sell unproven or disproven medicines? Pharm J 2008; 281: 75-76
47. Maguire T. We are what we sell: questionable quality and efficacy of slimming aids. Pharm J 2008; 281: 96
48. O'Donnell CA. Attitudes and knowledge of primary care professionals towards evidence-based practice: a postal survey. J Eval Clin Pract 2004; 10: 197-2005
49. Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar: pediatric cough and cold medications. N Engl J Med 2007; 357: 2321-2324
50. The Medicines and Healthcare products Regulatory Agency (MHRA). Children's over-the-counter cough and cold medicines: new advice [online]. Available from URL: http://www.mhra.gov.uk/Safetyinformation/ Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON038908 [Accessed 2009 Mar 27]
51. Malterud K. Qualitative research: standards, challenges and guidelines. Lancet 2001; 358: 483-488